Progress in genomics with, in particular, high throughput next generation sequencing is revolutionizing oncology. The impact of these techniques is seen on the one hand the identification of germline mutations that predispose to a given type of cancer, allowing for a personalized care of patients or healthy carriers and, on the other hand, the characterization of all acquired somatic mutation of the tumor cell, opening the door to personalized treatment targeting the driver oncogenes. In both cases, next generation sequencing techniques allow a global approach whereby the integrality of the genome mutations is analyzed and correlated with the clinical data. The benefits on the quality of care delivered to our patients are extremely impressi...
Cancer therapy has historically been determined by a tumor’s tissue of origin. Now, thanks to advanc...
With the development and improvement of new sequencing technology, next 鄄 generation sequencing (NG...
Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy ...
Progress in genomics with, in particular, high throughput next generation sequencing is revolutioniz...
Next generation sequencing (NGS) technology has revolutionized genomic analysis for disease research...
The necessary infrastructure to carry out genomics-driven oncology is now widely available and has r...
The finalization of the Human Genome Project in 2003 paved the way for a deeper understanding of can...
As a result of multiple technological and practical advances, high-throughput sequencing, known more...
Although the description and interpretation of cancer genetics has been at the core of cancer resear...
Recent years have brought about a marked extension of our understanding of the somatic basis of canc...
Precision medicine seeks to use genomic data to help provide the right treatment to the right patien...
International audienceTargeted therapies have revolutionized the treatment of many cancers. Widely d...
Colorectal cancer is the second leading cause of cancer death among men and women in the United Stat...
Somatic mutations and copy number alterations are the basis for cancer development and progression, ...
Targeted therapy against actionable gene mutations shows a significantly higher response rate as wel...
Cancer therapy has historically been determined by a tumor’s tissue of origin. Now, thanks to advanc...
With the development and improvement of new sequencing technology, next 鄄 generation sequencing (NG...
Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy ...
Progress in genomics with, in particular, high throughput next generation sequencing is revolutioniz...
Next generation sequencing (NGS) technology has revolutionized genomic analysis for disease research...
The necessary infrastructure to carry out genomics-driven oncology is now widely available and has r...
The finalization of the Human Genome Project in 2003 paved the way for a deeper understanding of can...
As a result of multiple technological and practical advances, high-throughput sequencing, known more...
Although the description and interpretation of cancer genetics has been at the core of cancer resear...
Recent years have brought about a marked extension of our understanding of the somatic basis of canc...
Precision medicine seeks to use genomic data to help provide the right treatment to the right patien...
International audienceTargeted therapies have revolutionized the treatment of many cancers. Widely d...
Colorectal cancer is the second leading cause of cancer death among men and women in the United Stat...
Somatic mutations and copy number alterations are the basis for cancer development and progression, ...
Targeted therapy against actionable gene mutations shows a significantly higher response rate as wel...
Cancer therapy has historically been determined by a tumor’s tissue of origin. Now, thanks to advanc...
With the development and improvement of new sequencing technology, next 鄄 generation sequencing (NG...
Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy ...